COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 3097: Articles 30961-30970  | Next

SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China
Wang, L., Li, X., Chen, H., Yan, S., Li, Y., Li, D., Gong, Z.
10.1101/2020.02.19.20025288 — Posted: 2020-02-23 Discussion: Onsite
The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province
Ai, J., Chen, J., Wang, Y., Liu, X., Fan, W., Qu, G., Zhang, M., Pei, S. P., Tang, B., Yuan, S., Li, Y., Wang, L., Huang, G., Pei, B.
10.1101/2020.02.19.20025023 — Posted: 2020-02-23
Early Prediction of Disease Progression in 2019 Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics
Feng, Z., Yu, Q., Yao, S., Luo, L., Duan, J., Yan, Z., Yang, M., Tan, H., Ma, M., Li, T., Yi, D., Mi, Z., Zhao, H., Jiang, Y., He, Z., Li, H., Nie, W., Liu, Y., Zhao, J., Luo, M., Liu, X., Rong, P., Wang, W.
10.1101/2020.02.19.20025296 — Posted: 2020-02-23
Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19
Ge, Y., McKay, B. K., Sun, S., Zhang, F., Handel, A.
10.1101/2020.02.20.20025973 — Posted: 2020-02-23
The efficacy of convalescent plasma for the treatment of severe influenza
Xu, Z., Zhou, J., Huang, Y., Liu, X., Xu, Y., Chen, S., Liu, D., Lin, Z., Liu, X., Li, Y.
10.1101/2020.02.20.20025593 — Posted: 2020-02-23
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing，China
lei, l., Jian-ya, G.
10.1101/2020.02.20.20025536 — Posted: 2020-02-23
Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus
Hou, T., Zeng, W., Yang, M., Chen, W., Ren, L., Ai, J., Wu, J., Liao, Y., Gou, X., Li, Y., Wang, X., Su, H., Wang, J., Gu, B., Xu, T.
10.1101/2020.02.22.20025460 — Posted: 2020-02-23 Discussion: Offsite
Estimating the Asymptomatic Ratio of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020
Mizumoto, K., Kagaya, K., Zarebski, A., Chowell, G.
10.1101/2020.02.20.20025866 — Posted: 2020-02-23
Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020
Mizumoto, K., Chowell, G.
10.1101/2020.02.19.20025163 — Posted: 2020-02-23 Discussion: Onsite
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China
Lu, J., Hu, S., Fan, R., Liu, Z., Yin, X., Wang, Q., Lv, Q., Cai, Z., Li, H., Hu, Y., Han, Y., Hu, H., Gao, W., Feng, S., Liu, Q., Li, H., Sun, J., Peng, J., Yi, X., Zhou, Z., Guo, Y., Hou, J.
10.1101/2020.02.20.20025510 — Posted: 2020-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).